Internal Medicine Alert – September 30, 2004
September 30, 2004
View Issues
-
A Puff of Prevention is Worth a Pound of ICU Care
Inhaled corticosteroids are the most effective pharmacologic agents in reducing exacerbations in asthmatics. -
Special Feature - LDL: Lower Is Better, but How Low Should We Go?
The newer, more potent, statin drugs are capable of reducing LDL cholesterol safely and tolerably in most patients thus making a target LDL of 50-70 mg/dL a practical goal, but how low is too low? -
Better Diagnosis of Celiac Disease
An NIH Consensus Panel has announced new recommendations for the diagnosis of celiac disease using new serologic testing. -
Pharmacology Update: Duloxetine Hydrochloride Capsules (Cymbalta)
The FDA has approved duloxetine for the treatment of depression and the management of the pain associated with diabetic peripheral neuropathy. -
Clinical Briefs
Peripheral arterial disease may be stratified in severity by the ankle-brachial index, measured by dividing the ankle systolic BP by the brachial systolic BP.